Biggest News Aggregation in the World
📰 Micron News

Page 38 - Micron News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Micron. Real-time updates on events, politics, business and more.

First semicon fab expected within a year, focus on components where India can lead: Vaishnaw, ET Auto

Electronic Chip Manufacturing Plant: "We are focussing on some niche area where we can take global leadership. Telecom and EV (electric vehicles) have emerged as a big segment for semiconductors. If we focus on developing and manufacturing chips used in these segments then we can become global leaders in these two segments," said Vaishnaw.
Tamil Nadu Aswhini Vaishnaw Centre For Development Of Advance Computing Union Telecom Digital India Advance Computing

Strong antibody response and nasal cytokines may protect young children from severe COVID-19

New research helps explain why young children have lower rates of severe COVID-19 than adults. A study of infants and young children found those who acquired SARS-CoV-2 had a strong, sustained antibody response to the virus and high levels of inflammatory proteins in the nose but not in the blood.
Stanford University United States Mary Allen Staat Bali Pulendran Danielle Ellis Violettal Horton

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine

Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorised the companies’ XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) in individuals 5 years and older.
New Zealand Lily Ramsey Ugur Sahin National Immunization Program Therapeutic Goods Administration Australian Technical Advisory Group On Immunization

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Moderna's updated mRNA-1273.815 COVID-19 vaccine shows promising results in reducing symptomatic cases, hospitalizations, and deaths in high-risk and older adults in Germany. The study finds the vaccine to be more cost-effective and clinically beneficial than both no vaccination and Pfizer's XBB.1.5 BNT162b2 vaccine.
Moderna Inc European Union Image Credit Covid 19 Global Health Ibonucleic Acid

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science